To carry out basic, translational and clinical research in sickle cell disease, The Sickle Cell Program at the University of North Carolina, Chapel Hill is a program created to provide comprehensive care to patients with the various sickle cell syndromes. Sickle cell disease affects approximately 100,000 people in the United States and is most prevalent in young, African American and Latino populations. Our Sickle Cell Clinical Program is staffed by professionals with a commitment to providing the best possible care to patients with sickle cell disease. The adult and pediatric sickle cell staff provides services to more than 300 adults and 250 children annually at our clinics at UNC, Chapel Hill.
- To provide excellent medical care to children and adults with sickle cell disease and related hemoglobinopathies
- To carry out basic, translational and clinical research in sickle cell disease
- To inform patients and their families, health care professionals and the community at large about sickle cell disease
- To provide psychosocial support and advocacy for people with sickle cell disease
- To analyze and improve on the health services systems within which medical care is delivered to children and adults with sickle cell disease
Kenneth I. Ataga, MD, Associate Professor of Medicine, is the director of the Sickle Cell Program. Rupa Redding-Lallinger, MD, Associate Professor of Pediatrics and Medicine, is co-director of the program. Eugene P. Orringer, MD, Professor of Medicine and Executive Associate Dean for Faculty Affairs, is the founding director of the program.